Nearly 40,000 bottles of eye drops recalled nationwide over possible contamination
See more of our coverage in your search results. Add The New York Post on Google.
See more of our coverage in your search results. Add The New York Post on Google.
Article outline
- What happened
- Why it matters
- The key numbers
- The bottom line
Key points
- Almost 40, 000 bottles of eye drops are being recalled nationwide due to potential contamination, according to the Food and Drug Administration.
- The affected product comes in 15-milliliter bottles with the lot code 2552A and an expiration date of Sep.
- They were distributed by Medtech Products Inc., a Prestige Consumer Healthcare firm.
- FOX Business reached out to Prestige Brands for comment.
- The FDA classified the recall as a Class II recall.
Tarrytown, New York-based Prestige Brand Holdings is voluntarily recalling 39, 060 bottles of its Clear Eyes Maximum Itchy Eye Relief eye drops due to a "lack of assurance of sterility, " according to an FDA enforcement report.
For context, the affected product comes in 15-milliliter bottles with the lot code 2552A and an expiration date of Sep. 30, 2027.
In practice, the FDA classified the recall as a Class II recall. It it describes as a "situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote." Other brands in the Prestige portfolio include Dramamine, Luden's and Anacin. Start your day with all you need to know. Morning Report delivers the latest news, videos, photos and more.
Meanwhile, the firm completed the acquisition of the Breathe Right brand – known for its nasal strips – and other assets from Foundation Consumer Healthcare in June in a agreement valued at regarding $1.05 billion. FOX Business reached out to Prestige Brands for comment.
Taken together, the developments around nearly 40, 000 bottles of eye drops recalled nationwide over possible contamination point to a situation that is still moving, and the coming days should bring more clarity.




